Upsher-Smith

Tuberous sclerosis complex (TSC) is a lifelong genetic condition that can cause noncancerous tumors in the brain, kidneys, heart, lungs, and skin. Its effects vary widely and may include seizures and autism spectrum disorder (ASD) manifestations.

Although TSC is classified as a rare disease, the impact on the people and families living with it is anything but rare. It shapes daily routines, influences major decisions, and calls for remarkable resilience.

Today, the stories of those affected bring visibility to experiences that often go unseen. And, as a company that provides therapies for certain individuals living with TSC, Upsher-Smith stands with this community in raising awareness and supporting continued progress.

Upsher-Smith is pleased to share new digital resources designed to support individuals living with Duchenne muscular dystrophy and the families and clinicians who care for them.

Our KYMBEE™ (deflazacort) Tablets caregiver and healthcare professional websites offer practical guidance on treatment access, helpful tools for caregivers, prescribing resources for clinicians, and information about the Promise of Support® Program.

Designed with the Duchenne community in mind, these platforms strive to provide access to trusted information quickly and confidently.

Click here to learn more: https://bit.ly/42euVOs

SELECT IMPORTANT SAFETY INFORMATION

KYMBEE (deflazacort) Tablets are a prescription medicine used to treat Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

Do not take if you have had hypersensitivity, including allergic reactions, to deflazacort (the active ingredient in KYMBEE) or to any of the inactive ingredients in KYMBEE.

Please see additional safety information: https://bit.ly/4tewBU3

And full Prescribing information: https://bit.ly/4sVyGUh

Honoring the physicians whose dedication drives progress in healthcare.

Your leadership and expertise make a profound impact on patients and communities. Today, we say thank you.